These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 22112055)

  • 1. Aberrant results observed with four immuno-assays for total and free prostate-specific antigen (PSA) determination: a case-report.
    Cavalier E
    Clin Chem Lab Med; 2011 Nov; 50(3):583-4. PubMed ID: 22112055
    [No Abstract]   [Full Text] [Related]  

  • 2. Assay-dependent abnormalities in measurements of prostate-specific antigen in serum: an occasional occurrence, but of clinical significance.
    Jung K; Stephan C; Lein M
    Clin Chem Lab Med; 2011 Dec; 50(3):585-6. PubMed ID: 22505526
    [No Abstract]   [Full Text] [Related]  

  • 3. A sensitive assay to measure biomarker glycosylation demonstrates increased fucosylation of prostate specific antigen (PSA) in patients with prostate cancer compared with benign prostatic hyperplasia.
    Dwek MV; Jenks A; Leathem AJ
    Clin Chim Acta; 2010 Dec; 411(23-24):1935-9. PubMed ID: 20708609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free and complexed prostate-specific antigen (PSA) in the early detection of prostate cancer.
    Tello FL; Prats CH; González MD
    Clin Chem Lab Med; 2001 Feb; 39(2):116-20. PubMed ID: 11341744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different stability of free and complexed prostate-specific antigen in serum in relation to specimen handling and storage conditions.
    Jung K; Lein M; Brux B; Sinha P; Schnorr D; Loening SA
    Clin Chem Lab Med; 2000 Dec; 38(12):1271-5. PubMed ID: 11205692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of free type and complex type prostate-specific antigen (PSA): differences in immunorecognition by Delfia PSA, ACS-PSA and Eiken PA kits].
    Sumi S; Umeda H; Koga F; Yano M; Imai T; Hosoya Y; Honda M; Maeda S; Suzuki T; Yoshida K; Negishi T
    Hinyokika Kiyo; 1996 Apr; 42(4):279-84. PubMed ID: 8693960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Case of persistent false elevation of prostate-specific antigen after radical prostatectomy].
    Shida Y; Imasato Y; Tsurusaki T; Kusaba Y
    Hinyokika Kiyo; 2010 Apr; 56(4):233-5. PubMed ID: 20448449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct electronic detection of prostate-specific antigen in serum.
    Briman M; Artukovic E; Zhang L; Chia D; Goodglick L; Gruner G
    Small; 2007 May; 3(5):758-62. PubMed ID: 17352433
    [No Abstract]   [Full Text] [Related]  

  • 9. Liaison free PSA--an automated chemiluminescent immunoassay for the determination of free prostate specific antigen (fPSA).
    König B; Ivankovic B; Schleff R; Mack M
    Anticancer Res; 1999; 19(4A):2763-5. PubMed ID: 10470237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated microfluidic systems with an immunosensor modified with carbon nanotubes for detection of prostate specific antigen (PSA) in human serum samples.
    Panini NV; Messina GA; Salinas E; Fernández H; Raba J
    Biosens Bioelectron; 2008 Feb; 23(7):1145-51. PubMed ID: 18162392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of PSA/free PSA with special reference to recent trends in diagnosis of prostatic cancer.
    Goyal SR; Talib VH; Khurana SK
    Indian J Pathol Microbiol; 1999 Apr; 42(2):171-8. PubMed ID: 10639780
    [No Abstract]   [Full Text] [Related]  

  • 12. Biases in antibody-based single-phase assays for free thyroxine due to protein-bound analyte.
    Tanhehco YC; Peck Palmer OM; Derrico LS; Sepulveda JL; Blair HC
    Clin Chim Acta; 2009 Aug; 406(1-2):176-8. PubMed ID: 19500559
    [No Abstract]   [Full Text] [Related]  

  • 13. Investigation of human anti-mouse antibodies as potential cause of postprostatectomy PSA elevation.
    Loeb S; Schaeffer EM; Chan DW; Carter HB; Walsh PC; Sokoll LJ
    Urology; 2009 May; 73(5):947-9. PubMed ID: 19394489
    [No Abstract]   [Full Text] [Related]  

  • 14. [PSA in women. Evaluation of its determination with polyclonal and monoclonal immunoassay].
    Morote Robles J; Reig Ruiz C; López Pacios MA; Lorente Garin JA; de Torres Mateos JA; Soler Rosello A
    Actas Urol Esp; 1994 Jan; 18(1):13-6. PubMed ID: 7514842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new modification of the Chiron ACS assay for total prostate-specific antigen achieves equimolar response characteristics and improves the detection of prostate cancer.
    Oberpenning F; Weining C; Brandt B; De Angelis G; Heinecke A; Hamm M; Stieber P; Hertle L; Schmid HP; Semjonow A
    Clin Chem Lab Med; 2003 Jan; 41(1):90-4. PubMed ID: 12636056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection.
    Jansen FH; van Schaik RH; Kurstjens J; Horninger W; Klocker H; Bektic J; Wildhagen MF; Roobol MJ; Bangma CH; Bartsch G
    Eur Urol; 2010 Jun; 57(6):921-7. PubMed ID: 20189711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of percent free PSA for early detection of prostate cancer.
    Potter SR; Reckwitz T; Partin AW
    J Androl; 1999; 20(4):449-53. PubMed ID: 10452585
    [No Abstract]   [Full Text] [Related]  

  • 18. Technicon Immuno 1 PSA assay measures both free and alpha-1-antichymotrypsin-complexed prostate-specific antigen on an equimolar basis.
    Zhou Z; Ng PC; Very DL; Allard WJ; Yeung KK
    J Clin Lab Anal; 1996; 10(3):155-9. PubMed ID: 8731504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review on the simultaneous determination of total prostate-specific antigen and free prostate-specific antigen.
    van Iersel MP; Witjes WP; Thomas CM; Segers MF; Oosterhof GO; Debruyne FM
    Prostate Suppl; 1996; 7():48-57. PubMed ID: 8950364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparability of serum prostate-specific antigen measurement between the Roche Diagnostics Elecsys 2010 and the Abbott Architect i2000.
    Gray MA; Cooke RR; Weinstein P; Nacey JN
    Ann Clin Biochem; 2004 May; 41(Pt 3):207-12. PubMed ID: 15117434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.